Essential role of interferon regulatory factor 4 (IRF4) in immune cell development

被引:0
|
作者
Sorim Nam
Jong-Seok Lim
机构
[1] Sookmyung Women’s University,Department of Biological Science
来源
关键词
Interferon regulatory factor 4 (IRF4); Lymphoid cells; Myeloid cells; Dendritic cells (DCs); Macrophages; Myeloid-derived suppressor cells (MDSCs);
D O I
暂无
中图分类号
学科分类号
摘要
The family of interferon regulatory factors, which includes nine mammalian members (IRF1–IRF9), acts as transcription factors for interferons and thus exerts regulatory functions in the immune system and in oncogenesis. Among these members, IRF4 expression is restricted to immune cells such as T and B lymphocytes, macrophages, and dendritic cells where it is a key factor in the regulation of differentiation and is required during the immune response for lymphocyte activation and the generation of immunoglobulin-secreting plasma cells. Consequently, dysregulation of IRF4 is associated with many lymphoid malignancies. Recent studies have demonstrated that depending on the context and stage of hematopoietic cell differentiation in which its expression is dysregulated, IRF4 may act as either an oncogene or a tumor-suppressor-like factor. In addition, it has been shown that IRF4 plays a pivotal role in the development and function of several autoimmune-associated cells. Various genetic and functional studies have also pointed to IRF4 as a master regulator for autoimmunity. In this review, the roles of IRF4 in the immune response are briefly summarized and discussed, with particular focus on its essential and distinct functions in immune cell development.
引用
收藏
页码:1548 / 1555
页数:7
相关论文
共 50 条
  • [31] Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4)
    Fanzo, JC
    Hu, CM
    Jang, SY
    Pernis, AB
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (03): : 303 - 314
  • [32] Expression of Interferon Regulatory Factor-4 (IRF4/MUM1) Is Associated with Inferior Overall Survival In Peripheral T-Cell Lymphoma
    Feldman, Andrew L.
    Dogan, Ahmet
    Maurer, Matthew J.
    Habermann, Thomas M.
    Johnston, Patrick B.
    Witzig, Thomas E.
    Slager, Susan
    Cerhan, James
    Ansell, Stephen M.
    BLOOD, 2010, 116 (21) : 66 - 66
  • [33] TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation
    Nayar, Ribhu
    Enos, Megan
    Prince, Amanda
    Shin, HyunMu
    Hemmers, Saskia
    Jiang, Jian-kang
    Klein, Ulf
    Thomas, Craig J.
    Berg, Leslie J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (41) : E2794 - E2802
  • [34] Molecular interactions of IRF4 in B cell development and malignancies
    Srinivasan Sundararaj
    Marco G. Casarotto
    Biophysical Reviews, 2021, 13 : 1219 - 1227
  • [35] Molecular interactions of IRF4 in B cell development and malignancies
    Sundararaj, Srinivasan
    Casarotto, Marco G.
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1219 - 1227
  • [36] IRF4 as an Oncogenic Master Transcription Factor
    Wong, Regina Wan Ju
    Ong, Jolynn Zu Lin
    Theardy, Madelaine Skolastika
    Sanda, Takaomi
    CANCERS, 2022, 14 (17)
  • [37] Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer
    Heimes, Anne-Sophie
    Madjar, K.
    Edlund, K.
    Battista, M. J.
    Almstedt, K.
    Gebhard, S.
    Foersch, S.
    Rahnenfuehrer, J.
    Brenner, W.
    Hasenburg, A.
    Hengstler, J. G.
    Schmidt, M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1123 - 1131
  • [38] Prognostic impact of interferon regulating factor 4 (IRF4) in node-negative breast cancer
    Heimes, A. -S.
    van de Sandt, L.
    Edlund, K.
    Battista, M.
    Sicking, I.
    Almstedt, K.
    Lebrecht, A.
    Rahnenfuehrer, J.
    Hengstler, J. G.
    Schmidt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 45 - 45
  • [39] Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer
    Anne-Sophie Heimes
    K. Madjar
    K. Edlund
    M. J. Battista
    K. Almstedt
    S. Gebhard
    S. Foersch
    J. Rahnenführer
    W. Brenner
    A. Hasenburg
    J. G. Hengstler
    M. Schmidt
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1123 - 1131
  • [40] Impaired expression of interferon regulatory factor 4 (IRF4) in chronic myeloid leukemia (CML) cell lines due to specific methylation of its promoter region.
    Friedrich, CA
    Schmidt, M
    Burchert, A
    Hoelzl, K
    Alpen, B
    Wittig, B
    Andreas, N
    BLOOD, 2001, 98 (11) : 257B - 257B